China’s Coronavirus Vaccine Ambition Hampered By Lack Of Guidance On Overseas Clinical Data
Global Objectives Meet Local Regulatory Murkiness
Executive Summary
As two Chinese-developed vaccines against COVID-19 enter the final stage of testing in Latin America and the Middle East, a lack of guidance on using data obtained outside China could potentially pose challenges to regulatory approvals at home.